Nicole Schneiderhan-Marra
Overview
Explore the profile of Nicole Schneiderhan-Marra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
93
Citations
1764
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fernandez-Carballo B, Atzeni M, Escadafal C, Vettoretti M, Geis S, Agnandji S, et al.
BMJ Open
. 2025 Feb;
15(2):e086912.
PMID: 39947818
Objectives: To evaluate the effectiveness of 18 different host biomarkers in differentiating bacterial from non-bacterial acute febrile illness (AFI) in resource-limited settings, specifically in Brazil, Malawi and Gabon. Design: Multinational,...
2.
Lehky M, Moonian T, Michel T, Junker D, Musken M, Strompl J, et al.
Protein Sci
. 2024 Dec;
34(1):e5251.
PMID: 39660966
The Hepatitis B surface antigen (HBsAg) as the only lipid-associated envelope protein of the Hepatitis B virus (HBV) acts as cellular attachment and entry mediator of HBV making it the...
3.
Chaturvedi M, Koster D, Bossuyt P, Gerke O, Jurke A, Kretzschmar M, et al.
Commun Med (Lond)
. 2024 Dec;
4(1):263.
PMID: 39658579
Evaluating diagnostic test accuracy during epidemics is difficult due to an urgent need for test availability, changing disease prevalence and pathogen characteristics, and constantly evolving testing aims and applications. Based...
4.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N, et al.
Vaccines (Basel)
. 2024 Nov;
12(11).
PMID: 39591144
Background: Patients with chronic liver disease (CLD) have impaired vaccine immunogenicity and an excess risk of severe COVID-19. While variant-adapted COVID-19 mRNA vaccines are recommended for vulnerable individuals, their efficacy...
5.
Frecot D, Blaess S, Wagner T, Kaiser P, Traenkle B, Fandrich M, et al.
Front Immunol
. 2024 Oct;
15:1480091.
PMID: 39474429
Purpose: Human OX40 (hOX40/CD134), a member of the TNF receptor superfamily, is mainly expressed on activated T lymphocytes. Triggered by its ligand OX40L (CD252), it provides costimulatory signals that support...
6.
Woelfel S, Dutschler J, Junker D, Konig M, Graf N, Krieger C, et al.
Aliment Pharmacol Ther
. 2024 Oct;
61(2):299-312.
PMID: 39468971
Background: Variant-adapted COVID-19 vaccines are recommended for patients with inflammatory bowel disease (IBD). However, many patients rely on pre-existing immunity by original vaccines or prior infections. Aim: To assess whether...
7.
Zimmermann M, Fandrich M, Jakobi M, Roben B, Wurster I, Lerche S, et al.
J Parkinsons Dis
. 2024 Sep;
14(7):1405-1416.
PMID: 39240648
Background: Prior investigations have elucidated pathophysiological interactions involving blood coagulation and neurodegenerative diseases. These interactions pertain to age-related effects and a mild platelet antiaggregant function of exogenous α-Synuclein. Objective: Our...
8.
Woelfel S, Dutschler J, Junker D, Konig M, Leinenkugel G, Graf N, et al.
Vaccines (Basel)
. 2024 Jul;
12(7).
PMID: 39066413
Recently updated COVID-19 mRNA vaccines encode the spike protein of the omicron subvariant XBB.1.5 and are recommended for patients with inflammatory bowel disease (IBD) on immunosuppressive treatment. Nonetheless, their immunogenicity...
9.
Zimmermann M, Fandrich M, Jakobi M, Roben B, Wurster I, Lerche S, et al.
Eur J Neurol
. 2024 Jul;
31(10):e16388.
PMID: 38946703
Background And Purpose: Parkinson's disease (PD) is an age-related condition characterized by substantial phenotypic variability. Consequently, pathways and proteins involved in biological aging, such as the central aging pathway comprising...
10.
Uzun G, Bareiss A, Becker M, Althaus K, Dulovic A, Junker D, et al.
J Clin Med
. 2024 Mar;
13(6).
PMID: 38541797
The prevalence of COVID-19 breakthrough infections in healthcare workers (HCWs) remains an issue of concern. This study examines the different characteristics associated with breakthrough infections in HCWs. From the total...